Stock comparison
Natera, Inc. is 6.6x more valuable than Caris Life Sciences, Inc. by market capitalization ($46.43 B vs $6.99 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
NTRA is larger
Natera, Inc. is 6.6x more valuable than Caris Life Sciences, Inc. by market capitalization ($46.43 B vs $6.99 B).
Market value leader
NTRA
Natera, Inc. is 6.6x more valuable than Caris Life Sciences, Inc. by market capitalization ($46.43 B vs $6.99 B).
Revenue leader
NTRA
NTRA: $2.31B vs CAI: $812.03M.
Profit leader
CAI
NTRA: -$208.16M vs CAI: -$68.09M.
Margin leader
CAI
NTRA: -9.0% vs CAI: -8.4% net margin.
| Metric | NTRA | CAI |
|---|---|---|
| Market cap | $46.43 B | $6.99 B |
| US-listed rank | #344 | #1170 |
| Revenue (latest FY) | $2.31B | $812.03M |
| Net income (latest FY) | -$208.16M | -$68.09M |
| Net margin | -9.0% | -8.4% |
| P/E (trailing FY) | - | - |
| SEC filings | 1,695 | 102 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Natera, Inc. is 6.6x more valuable than Caris Life Sciences, Inc. by market capitalization ($46.43 B vs $6.99 B).
In their latest fiscal years, Natera, Inc. reported $2.31B in revenue while Caris Life Sciences, Inc. reported $812.03M.
Full pages: Natera, Inc. and Caris Life Sciences, Inc., or browse the full rankings.